Sisram Medical Ltd (HKG:1696)
Hong Kong · Delayed Price · Currency is HKD 3.440
+0.080 (2.38%)
At close: Mar 27, 2026
Sisram Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 19.02 | 25.13 | 31.5 | 40.17 | 31.25 |
Depreciation & Amortization | 17.35 | 17.31 | 14.24 | 12.4 | 12.29 |
Loss (Gain) From Sale of Assets | - | -0.01 | -0.02 | - | - |
Asset Writedown & Restructuring Costs | - | 0.1 | - | - | - |
Loss (Gain) From Sale of Investments | - | -4.15 | - | - | - |
Loss (Gain) on Equity Investments | - | -0.03 | 0.42 | 0.52 | 0.31 |
Stock-Based Compensation | - | -0.79 | 0.49 | 3.17 | 0.29 |
Provision & Write-off of Bad Debts | - | 2.2 | 1.14 | 0.56 | 1.4 |
Other Operating Activities | 14.53 | 3.04 | 3.06 | 6.46 | 8.74 |
Change in Accounts Receivable | - | -13.93 | -3.79 | -16.24 | -23.36 |
Change in Inventory | - | -4.55 | -4.08 | -19.36 | -19.44 |
Change in Accounts Payable | - | 5.7 | -5.47 | 0.83 | 0.89 |
Change in Unearned Revenue | - | 0.23 | 1.78 | 0.07 | 5.75 |
Change in Other Net Operating Assets | -41.5 | 2.85 | 4.68 | -6.54 | 14.27 |
Operating Cash Flow | 9.4 | 33.08 | 43.94 | 22.04 | 32.38 |
Operating Cash Flow Growth | -71.59% | -24.70% | 99.36% | -31.93% | 25.80% |
Capital Expenditures | -2.6 | -2.75 | -8.57 | -4.75 | -2.97 |
Sale of Property, Plant & Equipment | - | 0.01 | 0.01 | 0.04 | - |
Cash Acquisitions | - | -1.76 | -32.22 | - | -43.27 |
Sale (Purchase) of Intangibles | - | -15.4 | - | -59.57 | - |
Investment in Securities | - | 12.16 | -3.31 | 15.96 | 3.88 |
Other Investing Activities | 0.9 | 1.14 | 11.09 | -3.79 | -4.42 |
Investing Cash Flow | -1.7 | -6.6 | -33 | -52.11 | -46.77 |
Short-Term Debt Issued | 24.6 | 7.55 | 4.44 | 5.89 | 3.08 |
Total Debt Issued | 24.6 | 7.55 | 4.44 | 5.89 | 3.08 |
Short-Term Debt Repaid | -18.7 | -7.11 | -5.68 | -6.97 | -5.18 |
Long-Term Debt Repaid | -8.4 | -7.2 | -5.97 | -4.98 | -4.63 |
Total Debt Repaid | -27.1 | -14.31 | -11.65 | -11.96 | -9.81 |
Net Debt Issued (Repaid) | -2.5 | -6.76 | -7.21 | -6.06 | -6.74 |
Issuance of Common Stock | - | - | - | - | 79.18 |
Common Dividends Paid | -10.4 | -9.45 | -10.51 | -9.33 | -4.19 |
Other Financing Activities | 1.98 | 0.09 | -3.24 | -2.46 | -12.47 |
Financing Cash Flow | -10.92 | -16.12 | -20.97 | -17.85 | 55.78 |
Foreign Exchange Rate Adjustments | 3.95 | -0.81 | -4.23 | -2.21 | 0.16 |
Net Cash Flow | 0.72 | 9.57 | -14.26 | -50.13 | 41.55 |
Free Cash Flow | 6.8 | 30.33 | 35.37 | 17.29 | 29.41 |
Free Cash Flow Growth | -77.59% | -14.23% | 104.62% | -41.23% | 78.66% |
Free Cash Flow Margin | 1.86% | 8.69% | 9.84% | 4.88% | 9.99% |
Free Cash Flow Per Share | 0.01 | 0.07 | 0.08 | 0.04 | 0.07 |
Cash Interest Paid | 0.7 | 0.25 | 0.49 | 0.43 | 0.39 |
Cash Income Tax Paid | - | 7.44 | 7.89 | 8.41 | 7.54 |
Levered Free Cash Flow | 3.04 | 32.29 | 9.27 | -42.56 | 4.23 |
Unlevered Free Cash Flow | 5.06 | 33.83 | 10.56 | -41.48 | 5.48 |
Change in Working Capital | -41.5 | -9.71 | -6.89 | -41.24 | -21.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.